Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES LAGERKRANTZ GROUP IN CONNECTION WITH ACQUISIITON OF LANDAUER NORDIC
Mandate

VINGE ADVISES LAGERKRANTZ GROUP IN CONNECTION WITH ACQUISIITON OF LANDAUER NORDIC

October 01, 2015

Vinge has advised Lagerkrantz Group in connection with the acquisition of Landauer Nordic from Landauer, Inc. Landauer Nordic develops and sells products and services for the measurement of radon. The company’s headquarters are situated in Uppsala and the company has a subsidiary in Chicago, USA. Landauer Nordic has an annual turnover of SEK 40 million with good profitability.

Vinge’s team consisted of partner Johan Winnerblad together with, among others, associates Filip Öhrner, Carl Sander, Evelina Tejle and Rebecka Weitzberg.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026